Related Experiment Video
Updated: Jul 9, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
Published on: February 20, 2019
Central and peripheral monoamine changes in a rat model of Gaming Disorder
Antonino Casile1, Brigitta Bonaldo2, Martina Bettarelli3
1University of Camerino, School of Pharmacy, Pharmacology Unit, Via Madonna delle Carceri, 9, 62032 Camerino, MC, Italy; Neuroscience Institute Cavalieri Ottolenghi (NICO), Regione Gonzole, 10, Orbassano, TO, Italy; University of Turin, 10043, Turin, Italy; Department of Neuroscience "Rita Levi-Montalcini", Via Cherasco 15, 10126, Turin, TO, Italy.
None:
Gaming Disorder (GD) is a mental disorder primarily affecting adolescents. Prolonged video game use can lead to behavioral alterations, such as loss of control, increased compulsivity, and symptoms of depression and anxiety. Studies in humans have shown changes in brain areas involved in emotional regulation and reward circuits, including the lateral hypothalamus (LH), ventral tegmental area (VTA), and dorsal (DRN) and median (MnR) raphe nuclei. These alterations appear to be linked to disrupted activity of orexin- (ORX), dopamine- (DA), and serotonin- (5-HT) positive (+) neurons. Our laboratory developed a rat model that mimics some symptoms of GD. Using immunohistochemistry and high-performance liquid chromatography, we analyzed ORX, DA, and 5-HT levels in rats exposed to the GD protocol. Compared to control groups, GD rats of both sexes exhibited a decreased density and number of ORX+, DA+, and 5-HT+ cells in the analyzed nuclei. Additionally, the reduction in DA+ and 5-HT+ neurons was associated with peripheral changes in their plasma levels and alterations in the tryptophan signaling pathway, accompanied by an increase in its inflammatory metabolites. These three systems are crucial for proper brain function, decision-making regulation, and the processing of emotional and reward-related stimuli. Our findings support the hypothesis that neurotransmitter dysfunction plays a key role in GD and provide a foundation for further research on the cerebral and behavioral changes observed in GD patients.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Abuse and Addiction: Pharmacological Phenomena
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

